Literature DB >> 12224503

Strategies for the identification and analysis of viral immune-evasive genes--cytomegalovirus as an example.

A Gutermann1, A Bubeck, M Wagner, U Reusch, C Ménard, U H Koszinowski.   

Abstract

Co-evolution of herpesviruses with their hosts has resulted in multiple interactions between viral genes and cellular functions. Some interactions control genomic maintenance and replication in specific tissues, other affect the immune control at various stages. Few immunomodulatory functions of genes can be predicted by sequence homology. The majority of genes with immunomodulatory properties only become apparent in functional assays. This chapter reviews procedures which have been used for successful identification of immunomodulatory genes in the past and deals with recent methods which may be applicable for the identification of additional immunomodulatory functions unknown so far.

Mesh:

Substances:

Year:  2002        PMID: 12224503     DOI: 10.1007/978-3-642-59421-2_1

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  12 in total

1.  Human cytomegalovirus blocks tumor necrosis factor alpha- and interleukin-1beta-mediated NF-kappaB signaling.

Authors:  Christina Montag; Jutta Wagner; Iris Gruska; Christian Hagemeier
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

2.  Role of murine cytomegalovirus US22 gene family members in replication in macrophages.

Authors:  Carine Ménard; Markus Wagner; Zsolt Ruzsics; Karina Holak; Wolfram Brune; Ann E Campbell; Ulrich H Koszinowski
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Mouse cytomegalovirus crosses the species barrier with help from a few human cytomegalovirus proteins.

Authors:  Qiyi Tang; Gerd G Maul
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  Direct interaction of the mouse cytomegalovirus m152/gp40 immunoevasin with RAE-1 isoforms.

Authors:  Li Zhi; Janet Mans; Michael J Paskow; Patrick H Brown; Peter Schuck; Stipan Jonjić; Kannan Natarajan; David H Margulies
Journal:  Biochemistry       Date:  2010-03-23       Impact factor: 3.162

5.  Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells.

Authors:  Edward P Browne; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

6.  Mouse cytomegalovirus microRNAs dominate the cellular small RNA profile during lytic infection and show features of posttranscriptional regulation.

Authors:  Lars Dölken; Jonathan Perot; Valérie Cognat; Abdelmalek Alioua; Matthias John; Jürgen Soutschek; Zsolt Ruzsics; Ulrich Koszinowski; Olivier Voinnet; Sébastien Pfeffer
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

Review 7.  Recombinant viruses as tools to study human cytomegalovirus immune modulation.

Authors:  Katrin Besold; Bodo Plachter
Journal:  Med Microbiol Immunol       Date:  2008-02-27       Impact factor: 3.402

8.  Dual analysis of the murine cytomegalovirus and host cell transcriptomes reveal new aspects of the virus-host cell interface.

Authors:  Vanda Juranic Lisnic; Marina Babic Cac; Berislav Lisnic; Tihana Trsan; Adam Mefferd; Chitrangada Das Mukhopadhyay; Charles H Cook; Stipan Jonjic; Joanne Trgovcich
Journal:  PLoS Pathog       Date:  2013-09-26       Impact factor: 6.823

9.  Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells.

Authors:  Andrea Loewendorf; Corinna Krüger; Eva Maria Borst; Markus Wagner; Ursula Just; Martin Messerle
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

10.  Temporal profiling of the coding and noncoding murine cytomegalovirus transcriptomes.

Authors:  Paul Lacaze; Thorsten Forster; Alan Ross; Lorraine E Kerr; Eliane Salvo-Chirnside; Vanda Juranic Lisnic; Guillermo H López-Campos; José J García-Ramírez; Martin Messerle; Joanne Trgovcich; Ana Angulo; Peter Ghazal
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.